When.com Web Search

  1. Ads

    related to: what are the new treatments available for copd prevention
    • Dosing And Administration

      Info On How To Self-Administer.

      Find Additional Support On The Site

    • FAQs

      Find Answers To Your Questions.

      Understand Treatment Options Now.

    • Copay Card

      See Potential Cost Savings.

      Learn More Here.

    • Treatment Support

      Discover Educational Resources.

      Get Financial Support Information.

Search results

  1. Results From The WOW.Com Content Network
  2. A new drug developed by a company with US headquarters in Raleigh, Ohtuvayre, was approved by the FDA Wednesday to help COPD patients manage symptoms.

  3. The Most Exciting New Advances in Managing COPD - AOL

    www.aol.com/most-exciting-advances-managing-copd...

    For people with COPD—and their care providers—the future looks bright. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Mail ...

  4. Chronic obstructive pulmonary disease - Wikipedia

    en.wikipedia.org/wiki/Chronic_obstructive...

    Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production or exacerbations) due to abnormalities of the airways (bronchitis ...

  5. Ensifentrine - Wikipedia

    en.wikipedia.org/wiki/Ensifentrine

    Ensifentrine, sold under the brand name Ohtuvayre, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD) in adults. [1] It is a phosphodiesterase 3 inhibitor and phosphodiesterase 4 inhibitor. [1] It is given by inhalation. [1] PDE3 inhibitors act as bronchodilators, while PDE4 inhibitors have an anti ...

  6. Global Initiative for Chronic Obstructive Lung Disease

    en.wikipedia.org/wiki/Global_Initiative_for...

    [1] [2] They have organized the annual awareness day, World COPD Day, every November since 2002. [3] This organization issues recommendations for the treatment of chronic obstructive pulmonary disease and related medical conditions. GOLD issued its first formal recommendations in 2001. [2]

  7. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14]

  1. Ads

    related to: what are the new treatments available for copd prevention